Iris Metastasis from Small-Cell Lung Cancer

Slides:



Advertisements
Similar presentations
Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Advertisements

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.
A Hole in the Heart Journal of Thoracic Oncology
Next Generation Sequencing Uncovers Potential Genetic Driver Mutations of Malignant Pulmonary Granular Cell Tumor  Song Xu, Qingchun Zhao, Sen Wei, Yi.
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis  Matthew Koshy, MD, Renuka Malik,
ALK FISH and IHC: You Cannot Have One without the Other
Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D
Radiotherapy Rescue of a Nivolumab-Refractory Immune Response in a Patient with PD-L1–Negative Metastatic Squamous Cell Carcinoma of the Lung  Zhigang.
Response to Osimertinib in Choroidal Metastases from EGFRmt T790M–Positive Non– Small Cell Lung Adenocarcinoma  Filippo Gustavo Dall’Olio, MD, Celeste.
Nivolumab Enhances the Inflammation of the Irradiation Field in Advanced Non–Small Cell Lung Cancer  Hiromi Furuta, MD, PhD, Tatsuya Yoshida, MD, PhD,
Influence of Preoperative Radiation Field on Postoperative Leak Rates in Esophageal Cancer Patients after Trimodality Therapy  Aditya Juloori, BS, Susan.
Ellen M. Schultz, MS, Gerard A. Silvestri, MD, MS, Michael K
NA  Journal of Thoracic Oncology 
Electronic Updates for JTO Readers
The Moth-Eaten Lung Journal of Thoracic Oncology
Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non–Small-Cell Lung Cancer: What We Have Learned  Joe Y. Chang, MD, PhD, Andrea Bezjak,
Tracheoesophageal Fistula Associated with Bevacizumab 21 Months after Completion of Radiation Therapy  Elizabeth Gore, MD, Adam Currey, MD, Nicholas Choong,
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
Frank Detterbeck, MD  Journal of Thoracic Oncology 
Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.
The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials  Krista.
Toxicities of Organs at Risk in the Mediastinal and Hilar Regions Following Stereotactic Body Radiotherapy for Centrally Located Lung Tumors  Shuichi.
Kiran Devisetty, MD, Joseph K. Salama, MD  Journal of Thoracic Oncology 
Effective Treatment with Icotinib in Primary Adenoid Cystic Carcinoma of the Lung with Liver Metastasis  Zhengbo Song, MD, Wei Wu, MD, Yiping Zhang, MD 
Technical Advances of Radiation Therapy for Thymic Malignancies
Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors  Benny Weksler, MD, Anthony Holden, MD, Jennifer.
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review  Arianna Casagrande, MD, Federica Pederiva,
Socioeconomic Status Is Associated with Depressive Severity Among Patients with Advanced Non–Small-Cell Lung Cancer: Treatment Setting and Minority Status.
A Hole in the Heart Journal of Thoracic Oncology
In This Issue Journal of Thoracic Oncology
Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database 
Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer
A Different Method in Diagnosis of Multiple Primary Lung Cancer
Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response 
Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS 
Heidi B. Rolke, Frode Gallefoss  Journal of Thoracic Oncology 
Stereotactic Body Radiotherapy in Patients with Previous Pneumonectomy: Safety and Efficacy  Robert Thompson, MD, Meredith Giuliani, MBBS, Mei Ling Yap,
Iris Metastasis in Small-Cell Lung Carcinoma
Nasion Swelling as the Presenting Symptom of Lung Adenocarcinoma
Mitotic Inhibitors Journal of Thoracic Oncology
A Case of Nontuberculous Mycobacteria Highly Suspected as Lung Cancer Invading the Aortic Arch  Tadashi Umehara, MD, Masaya Aoki, MD, PhD, Aya Harada,
Mirror Mirror on the Wall, Who Is the Fairest of Them All
EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer  Allison Ackerman, MD, Michael A. Goldstein,
Dose-per-Fraction Escalation of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy in Locally Advanced Non-small Cell Lung Cancer 
Multiple Primary Cancers or Multiple Metastases, That Is the Question
Role of Postoperative Radiotherapy in Nonlocalized Thymoma
Patterns of Local and Nodal Failure in Malignant Pleural Mesothelioma After Extrapleural Pneumonectomy and Photon-Electron Radiotherapy  Vishal Gupta,
Phase I Study of Lenalidomide in Solid Tumors
Gaurav Marwaha, MD, Kevin L. Stephans, MD, Neil M
Jie Huang, Juan Peng, Linlang Guo, MD, PhD 
In This Issue Journal of Thoracic Oncology
International Thymic Malignancies Interest Group: A Way Forward
European Lung Cancer Conference (ELCC) 2016 Organisation
Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.
Todd J. Carpenter, MD, Kenneth E. Rosenzweig, MD 
IASLC 6th Latin American Conference on Lung Cancer
Tumor Lysis Syndrome in Limited-Stage Small-Cell Lung Cancer
APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28
David Garfield, MD  Journal of Thoracic Oncology 
Stereotactic Body Radiotherapy for Central Lung Tumors
Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.
A Review of First-Line Treatment for Small-cell Lung Cancer
Robert Comis, MD, The Passing of a “Lung Man”
Dose-Escalated Stereotactic Body Radiotherapy (SBRT) as a Salvage Treatment for Two Cases with Relapsed Peripheral Lung Cancer After Initial SBRT  Shuichi.
Ana Luque, MD, Edurne Arriola, MD, PhD  Journal of Thoracic Oncology 
Presentation transcript:

Iris Metastasis from Small-Cell Lung Cancer Masaharu Hata, MD, Tomio Inoue, MD  Journal of Thoracic Oncology  Volume 9, Issue 10, Pages 1584-1585 (October 2014) DOI: 10.1097/JTO.0000000000000201 Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Photograph of a computed tomography slice showing the isodose distribution in the right eye using a radiotherapy simulation model. Electron beams are delivered through an anterior port to the iris, which is homogeneously encompassed within the 100% dose level. The radiation dose to the ocular fundus is reduced to less than 50% of the prescribed dose because of rapid dose falloff. Journal of Thoracic Oncology 2014 9, 1584-1585DOI: (10.1097/JTO.0000000000000201) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Photographs of the site of the metastatic tumor derived from small-cell lung cancer in the iris of the right eye, (A) before and (B) at the completion of radiotherapy. The metastatic tumor had completely disappeared after treatment and only residual pigmentation remained. Journal of Thoracic Oncology 2014 9, 1584-1585DOI: (10.1097/JTO.0000000000000201) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions